Anemia of Chronic Disease (Anemia of Inflammation): Causes, Pathophysiology, Clinical Features, and Diagnosis
Introduction
Anemia of Chronic Disease (ACD), also known as Anemia of Inflammation (AI), is the second most common type of anemia after iron deficiency anemia. It develops as a complication of chronic inflammatory disorders rather than a primary hematologic disease. Patients with chronic infections, autoimmune diseases, malignancies, or chronic kidney disease are at increased risk of developing this condition.
Unlike iron deficiency anemia, the body usually contains sufficient or even increased iron stores. However, persistent inflammation alters normal iron metabolism, preventing iron from being efficiently utilized for hemoglobin synthesis and red blood cell production. As a result, patients develop mild to moderate anemia despite having adequate iron reserves.
Anemia of Chronic Disease is one of the most common types of anemia. To learn more about anemia, including its classification, causes, symptoms, diagnosis, and treatment, read our https://smartmedixlab.blogspot.com/2026/07/anemia-causes-symptoms-diagnosis.htmlcomplete guide on Anemia.
What Is Anemia of Chronic Disease?
Definition
Anemia of Chronic Disease is an acquired anemia that occurs in association with chronic inflammatory, infectious, autoimmune, or malignant disorders. It results from impaired iron utilization, reduced erythropoietin activity, and suppression of erythropoiesis by inflammatory mediators.
The condition is also called Anemia of Inflammation because inflammation is the primary mechanism responsible for its development.
Why Does It Occur?
During chronic inflammation, the immune system releases cytokines that interfere with normal red blood cell production. These cytokines stimulate the production of hepcidin, a hormone that regulates iron metabolism. Increased hepcidin prevents iron from reaching the bone marrow, reducing hemoglobin synthesis even though iron stores remain adequate.
Causes of Anemia of Chronic Disease
Several chronic illnesses can lead to the development of ACD. The most common causes include chronic infections, autoimmune diseases, malignancies, and chronic organ diseases.
Chronic Infections
Persistent infections can continuously stimulate the immune system, leading to prolonged inflammation and impaired iron metabolism.
Examples include:
Tuberculosis
HIV infection
Osteomyelitis
Infective endocarditis
Chronic pneumonia
Lung abscess
Chronic urinary tract infection
Autoimmune and Inflammatory Diseases
Inflammatory disorders are among the leading causes of ACD because they produce large amounts of inflammatory cytokines.
Common examples include:
Rheumatoid arthritis
Systemic lupus erythematosus (SLE)
Inflammatory bowel disease
Vasculitis
Malignancies
Both hematological and solid malignancies may cause chronic inflammation and suppress erythropoiesis.
Examples include:
Leukemia
Lymphoma
Multiple myeloma
Solid tumors
Other Causes
Other conditions associated with ACD include:
Chronic kidney disease
Chronic liver disease
Other long-standing inflammatory disorders
Pathophysiology
The development of Anemia of Chronic Disease involves several mechanisms that work together to reduce red blood cell production.
Increased Inflammatory Cytokines
Chronic inflammation stimulates immune cells to release inflammatory cytokines, including:
Interleukin-6 (IL-6)
Interleukin-1 (IL-1)
Tumor necrosis factor-alpha (TNF-α)
Interferon-gamma (IFN-γ)
These cytokines suppress normal erythropoiesis and alter iron metabolism.
Increased Hepcidin Production
Among these cytokines, IL-6 plays the most important role by stimulating the liver to produce hepcidin.
Hepcidin blocks the iron transport protein ferroportin, preventing iron from leaving macrophages and intestinal cells. Consequently, iron becomes trapped within storage sites, resulting in low circulating iron despite normal or increased body iron stores.
Reduced Erythropoietin Activity
Inflammatory cytokines decrease erythropoietin production by the kidneys and reduce the responsiveness of erythroid precursor cells in the bone marrow. Consequently, fewer red blood cells are produced.
Shortened Red Blood Cell Survival
Inflammation also shortens the lifespan of circulating red blood cells, contributing further to anemia.
Clinical Features
The symptoms of ACD usually develop gradually and are often less severe than those seen in other types of anemia.
Symptoms of Anemia
Common symptoms include:
Fatigue
Generalized weakness
Pallor
Reduced exercise tolerance
Shortness of breath on exertion
Dizziness
Symptoms of the Underlying Disease
Because ACD develops secondary to chronic illnesses, patients often present with symptoms related to the primary disorder, such as:
Fever
Chronic cough
Joint pain and stiffness
Weight loss
Night sweats
Enlarged lymph nodes
Laboratory Findings
Laboratory investigations help distinguish ACD from other causes of anemia.
Complete Blood Count (CBC)
CBC typically demonstrates:
Mild to moderate anemia
Hemoglobin usually between 8–11 g/dL
Normocytic normochromic red blood cells
Mild microcytic hypochromic anemia in long-standing disease
Iron Studies
Typical iron profile includes:
Low serum iron
Low total iron-binding capacity (TIBC)
Normal or increased serum ferritin
Reduced transferrin saturation
These findings indicate impaired iron utilization rather than true iron deficiency.
Other Laboratory Findings
Additional investigations may reveal:
Normal or slightly decreased reticulocyte count
Elevated erythrocyte sedimentation rate (ESR)
Increased C-reactive protein (CRP)
Diagnosis
Clinical Assessment
Diagnosis begins with identifying an underlying chronic inflammatory, infectious, autoimmune, malignant, or renal disease. A detailed history and physical examination are essential to determine the underlying cause.
Laboratory Evaluation
The diagnosis is supported by CBC and iron studies showing low serum iron, decreased TIBC, and normal or elevated ferritin levels. These findings help differentiate Anemia of Chronic Disease from iron deficiency anemia, where ferritin is typically reduced.
Treatment
The primary goal of treating Anemia of Chronic Disease (ACD) is to control the underlying disease responsible for chronic inflammation. In many patients, anemia gradually improves once the primary condition is effectively managed. Unlike iron deficiency anemia, routine iron supplementation is not recommended unless true iron deficiency is also present.
Treating the Underlying Cause
Managing the underlying disease is the most effective approach to correcting ACD. Treatment varies according to the cause and may include:
Antibiotics for chronic bacterial infections.
Immunosuppressive or anti-inflammatory medications for autoimmune diseases.
Chemotherapy, targeted therapy, or other cancer treatments for malignancies.
Appropriate management of chronic kidney disease and other chronic medical conditions.
Successful control of inflammation reduces cytokine production, improves iron utilization, and restores normal erythropoiesis.
Intravenous Iron Therapy
Intravenous (IV) iron may be beneficial in selected patients, particularly those with functional iron deficiency or chronic kidney disease. Since increased hepcidin reduces intestinal iron absorption, IV iron bypasses this mechanism and delivers iron directly into the circulation.
Erythropoiesis-Stimulating Agents (ESAs)
Patients with chronic kidney disease or chemotherapy-associated anemia may benefit from erythropoiesis-stimulating agents such as epoetin alfa or darbepoetin alfa. These medications stimulate bone marrow to increase red blood cell production and help improve hemoglobin levels.
Blood Transfusion
Blood transfusion is reserved for patients with severe symptomatic anemia or when rapid correction of hemoglobin is necessary. Because repeated transfusions may lead to iron overload and other complications, they are not considered a long-term treatment strategy.
Prognosis
The prognosis of Anemia of Chronic Disease depends largely on the successful management of the underlying disorder. In many patients, anemia improves or resolves once chronic inflammation is adequately controlled.
However, persistent anemia may indicate ongoing disease activity and is associated with poorer outcomes in conditions such as chronic kidney disease, heart failure, and malignancies. Even mild anemia can reduce quality of life by causing fatigue, weakness, and decreased physical performance.
Early diagnosis and appropriate treatment of both the anemia and its underlying cause generally result in a favorable prognosis and improved long-term outcomes.
Conclusion
Anemia of Chronic Disease is a common complication of chronic inflammatory, infectious, autoimmune, and malignant disorders. Although body iron stores are usually adequate, inflammation prevents iron from being effectively utilized for red blood cell production. Laboratory findings, particularly iron studies, are essential for differentiating ACD from iron deficiency anemia. Since the condition reflects an underlying disease rather than a primary hematologic disorder, successful treatment focuses on controlling the underlying cause. Early recognition and appropriate management can significantly improve patient outcomes and quality of life.
Frequently Asked Questions (FAQs)
Is Anemia of Chronic Disease the same as iron deficiency anemia?
No. Although both conditions present with low serum iron, patients with ACD usually have normal or increased iron stores and elevated serum ferritin, whereas iron deficiency anemia is characterized by depleted iron stores and low ferritin levels.
Why is ferritin increased in Anemia of Chronic Disease?
Ferritin is an acute-phase protein that increases during inflammation. In ACD, iron becomes trapped inside storage cells, resulting in normal or elevated ferritin despite reduced circulating iron.
What is the role of hepcidin in ACD?
Hepcidin is a hormone produced by the liver during inflammation. It blocks iron release from macrophages and reduces intestinal iron absorption, limiting the availability of iron for hemoglobin synthesis.
Can Anemia of Chronic Disease be cured?
In many cases, the anemia improves or resolves once the underlying disease is successfully treated. The outcome depends mainly on the severity and control of the primary condition.
Is oral iron effective in Anemia of Chronic Disease?
Oral iron is generally less effective because inflammation increases hepcidin levels, which reduce intestinal iron absorption. Iron therapy is usually reserved for patients with confirmed iron deficiency or selected clinical situations.
References
Hoffbrand, A. V., & Moss, P. A. H. (2024). Essential Haematology (9th ed.). Wiley-Blackwell.
Cappellini, M. D., Motta, I. (2021). Anemia in Clinical Practice: Definition and Classification. Springer.
Means, R. T. (2023). Anemia of Inflammation (Anemia of Chronic Disease). MSD Manual Professional Edition.
National Center for Biotechnology Information (NCBI). Anemia of Chronic Disease. StatPearls Publishing.
Course Lecture Notes: Anemia of Chronic Disease (Anemia of Inflammation). Medical Laboratory Sciences.






Comments
Post a Comment